Arkolith/Insider Trading/AKTX/Form 4

Gaslightwala Abizer

CEO, DirectorAkari Therapeutics Plc (AKTX) · full profile →Form 4 · filed Aug 29, 2025
Net Buying
Open-Market Buys
$20K
Open-Market Sells
$0
Net Open-Market Flow
$20K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 25, 2025Buy(P)3K$0.90$3K299K
Aug 22, 2025Buy(P)8K$0.93$7K296K
Aug 21, 2025Buy(P)10K$0.94$9K288K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001641172-25-026025) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML